EVL and B-cell non-Hodgkin lymphoma: EVL/MIR342 was found to be methylated in 68 (68.7%) B cell lymphoma and eight (24.2%) T cell lymphoma (Table 1, Fig. 3a), hence preferentially methylated in B cell lymphoma (P < 0.0001).